Atrium Health Gastroenterology and Hepatology Kenilworth
Charlotte, North Carolina, 28204, United States
NCT Number: NCT06732453
The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Charlotte, North Carolina, 28204, United States
This research looks to adapt an existing seated yoga intervention, designed for patients with GI cancer, for testing in patients with disorders of the upper GI tract by conducting a field test with FD-GP patients to assess feasibility and acceptability and refine the adapted intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two one-hour chair-based yoga sessions that will include gentle movements, breathing practices, and meditation, along with home practice.
Time frame: Week 0
Tracking the number of screened participants, those who are eligible, and the percent who agree to participate.
Time frame: Week 0
Total number of patients who enrolled and proportion of patients eligible who enrolled
Time frame: Week 2
Total number of participants who enrolled in the study who remained until completion
Time frame: Week 2
Completion of 75% of the planned in-person sessions will be considered adherent; home practice will be tracked via daily logs sent back to study team electronically.
Time frame: Week 2
Amount of time needed for assessments.
Time frame: Week 2
Overall acceptability of intervention. Target acceptability ratings of at least 4 (agree/completely agree) on a scale of 1 to 5, with a score of 5 being the most acceptable.
Time frame: Week 2
Assesses satisfaction with treatment. Scores range from 8 to 32; higher scores indicate more satisfaction.
Time frame: Week 2
Measures intervention usability. Scores range from 0-100; a score of 70 or greater may be considered adequate.
Time frame: Week 1, Week 2
Acute effects using a VAS scale of nausea and psychological distress ranging 0 (none at all) to 100 (as much as there could be) before and after each session to assess immediate relief of symptoms. Higher scores indicate more nausea and psychological distress.
Time frame: Week 2
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Time frame: Week 3
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Time frame: Week 4
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Wake Forest University Health Sciences
Other
Adaptation of the Yoga Skills Training for Relief of Nausea and Vomiting in Patients With Functional Dyspepsia and Gastroparesis
Acronym: FD-GP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07474415
Digestive System Diseases, Functional Dyspepsia
Columbus, Ohio, United States
View Trial DetailsNCT06500130
Chronic Nausea and Vomiting Syndrome, Digestive System Diseases
Auckland, New Zealand
View Trial DetailsNCT06854120
Digestive System Diseases, Functional Dyspepsia
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05812339
Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders
Calgary, Alberta, Canada
View Trial Details